Juntao Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juntao Hu has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Zhanhong Tang
Intensive Care Unit, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China
4 shared publications Jie Lai
Department of Critical Care Medicine, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, People’s Republic of China
3 shared publicationsLiangyan Jiang
3 shared publications- Wanchun Tang
Weil Institute of Emergency and Critical Care Research, Virginia Commonwealth University, Richmond, Virginia
3 shared publications - Weiwei Ge
Shenzhen Hospital of Southern Medical University, Shenzhen, China
3 shared publications - Fenglian He
Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
2 shared publications
Latest Publications
- Open Access
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-13
Pancreatitis in Women of Reproductive Age: Global Burden, Rising Incidence in Youth, and Forecasts to 2050
Objective: Given the limited epidemiological evidence specifically focusing on women of reproductive age, this study aimed to systematically assess the global disease burden trends of pancreatitis among women aged 15– 49 from 1990 to 2021 and forecasts its projected burden from 2022 to 2050. Methods: Using open data from the Global Burden of Disease (GBD) database, we calculated temporal trends in the disease burden using the Joinpoint regression model and age-period-cohort (APC) analysis, and projected the disease burden of pancreatitis from 2022 to 2050 using the Bayesian Age-Period-Cohort Model (BAPC). Results: From 1990 to 2021, the global age-standardized incidence rate (ASIR) and disability-adjusted life years (DALY) rate showed overall downward trends [estimated annual percentage change (EAPC) = − 0.37 and − 0.80, respectively]. Conversely, ASIR exhibited upward trends in low-middle and low socio-demographic index (SDI) regions (EAPC = 0.30 and 0.12), and notably among young women under 25 (EAPC = 0.45 for ages 15– 19). Eastern Europe had the highest age-standardized DALY rate (116.37) in 2021 and was the only region with an increased burden (EAPC = 1.36). APC analysis revealed the highest local drift in ASIR for women aged 15– 19 (0.31). BAPC forecasts indicate the global ASIR will continue to rise and accelerate, reaching 28.10 by 2050. Conclusion: From 1990 to 2021, the burden of acute pancreatitis declined significantly in women aged 15– 49, while low and low middle SDI experienced an upward trend in ASIR, whereas younger age groups (< 25) saw rising ASIR rates. Eastern Europe was the only worsening trend. APC analysis revealed 15– 19 age group experienced the most localized ASIR drift. Prospective projections indicate this population will continue to accelerate by 2050.
- 1 May 2026
- Published by Taylor & Francis in International Journal of Women's Health
- Vol. ume 18, 1-13
Open AccessPancreatitis in Women of Reproductive Age: Global Burden, Rising Incidence in Youth, and Forecasts to 2050
Objective: Given the limited epidemiological evidence specifically focusing on women of reproductive age, this study aimed to systematically assess the global disease burden trends of pancreatitis among women aged 15– 49 from 1990 to 2021 and forecasts its projected burden from 2022 to 2050. Methods: Using open data from the Global Burden of Disease (GBD) database, we calculated temporal trends in the disease burden using the Joinpoint regression model and age-period-cohort (APC) analysis, and projected the disease burden of pancreatitis from 2022 to 2050 using the Bayesian Age-Period-Cohort Model (BAPC). Results: From 1990 to 2021, the global age-standardized incidence rate (ASIR) and disability-adjusted life years (DALY) rate showed overall downward trends [estimated annual percentage change (EAPC) = − 0.37 and − 0.80, respectively]. Conversely, ASIR exhibited upward trends in low-middle and low socio-demographic index (SDI) regions (EAPC = 0.30 and 0.12), and notably among young women under 25 (EAPC = 0.45 for ages 15– 19). Eastern Europe had the highest age-standardized DALY rate (116.37) in 2021 and was the only region with an increased burden (EAPC = 1.36). APC analysis revealed the highest local drift in ASIR for women aged 15– 19 (0.31). BAPC forecasts indicate the global ASIR will continue to rise and accelerate, reaching 28.10 by 2050. Conclusion: From 1990 to 2021, the burden of acute pancreatitis declined significantly in women aged 15– 49, while low and low middle SDI experienced an upward trend in ASIR, whereas younger age groups (< 25) saw rising ASIR rates. Eastern Europe was the only worsening trend. APC analysis revealed 15– 19 age group experienced the most localized ASIR drift. Prospective projections indicate this population will continue to accelerate by 2050.
- Open Access
Knowledge, attitudes and practices of intensive care unit physicians towards the management of acute respiratory distress syndrome in China: a cross-sectional survey
Objectives This study aimed to assess the knowledge, attitudes and practices (KAP) of intensive care unit (ICU) physicians in China towards acute respiratory distress syndrome (ARDS). Design A cross-sectional study was conducted between September and November 2022. Participants A total of 497 ICU physicians participated, with 258 (51.91%) being male and the majority aged 30–40 years (56.74%). Interventions Participants were surveyed to evaluate their KAP regarding ARDS, with mediation analysis employed to elucidate the association between demographic characteristics and KAP scores. Primary and secondary outcome measures The mean scores for KAP were 11.89±2.64 (range: 0–17), 44.73±4.85 (range: 12–60) and 18.26±3.43 (range: 1–48), respectively. Pearson correlation analysis showed positive correlations between knowledge and attitude (0.367), knowledge and practice (0.582) and attitude and practice (0.314) (all pResults Mediation analysis indicated that attitude (β=0.07, pConclusions ICU physicians in China exhibited inadequate knowledge, moderate attitudes and suboptimal practices regarding ARDS management. Enhancing education and work experience is crucial, along with practical, scenario-based training, to improve KAP in ARDS management.
Open AccessKnowledge, attitudes and practices of intensive care unit physicians towards the management of acute respiratory distress syndrome in China: a cross-sectional survey
Objectives This study aimed to assess the knowledge, attitudes and practices (KAP) of intensive care unit (ICU) physicians in China towards acute respiratory distress syndrome (ARDS). Design A cross-sectional study was conducted between September and November 2022. Participants A total of 497 ICU physicians participated, with 258 (51.91%) being male and the majority aged 30–40 years (56.74%). Interventions Participants were surveyed to evaluate their KAP regarding ARDS, with mediation analysis employed to elucidate the association between demographic characteristics and KAP scores. Primary and secondary outcome measures The mean scores for KAP were 11.89±2.64 (range: 0–17), 44.73±4.85 (range: 12–60) and 18.26±3.43 (range: 1–48), respectively. Pearson correlation analysis showed positive correlations between knowledge and attitude (0.367), knowledge and practice (0.582) and attitude and practice (0.314) (all pResults Mediation analysis indicated that attitude (β=0.07, pConclusions ICU physicians in China exhibited inadequate knowledge, moderate attitudes and suboptimal practices regarding ARDS management. Enhancing education and work experience is crucial, along with practical, scenario-based training, to improve KAP in ARDS management.
- Open Access
- 1 October 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 7687-7704
Moderate Hypothermia Alleviates Sepsis-Associated Acute Lung Injury by Suppressing Ferroptosis Induced by Excessive Inflammation and Oxidative Stress via the Keap1/GSK3β/Nrf2/GPX4 Signaling Pathway
Purpose: Sepsis-associated acute lung injury (SA-ALI) is a common complication in patients with sepsis, contributing to high morbidity and mortality. Excessive inflammation and oxidative stress are crucial contributors to lung injury in sepsis. This study aims to examine the protective effects of moderate hypothermia on SA-ALI and explore the underlying mechanisms. Methods: Sepsis was induced in rats through cecal ligation and puncture followed by intervention with moderate hypothermia (32– 33.9°C). Blood, bronchoalveolar lavage fluid, and lung tissues were collected 12 hours post-surgery. Inflammatory responses, oxidative injury, SA-ALI-related pathophysiological processes, and Keap1/GSK3β/Nrf2/GPX4 signaling in septic rats were observed by ELISA, lung W/D ratio, immunohistochemistry, immunofluorescence, histological staining, Western blotting, RT-qPCR, and TEM assays. Results: Moderate hypothermia treatment alleviated lung injury in septic rats, reflected in amelioration of pathological changes in lung structure and improved pulmonary function. Further, moderate hypothermia reduced arterial blood lactate production and suppressed the expression of inflammatory factors IL-1β, IL-6, and TNF-α; downregulated ROS, MDA, and redox-active iron levels; and restored GSH and SOD content. TEM results demonstrated that moderate hypothermia could mitigate ferroptosis in PMVECs within lung tissue. The underlying mechanism may involve regulation of the Keap1/Nrf2/SLC7A11/GPX4 signaling pathway, with the insulin pathway PI3K/Akt/GSK3β also playing a partial role. Conclusion: Collectively, we illustrated a novel potential therapeutic mechanism in which moderate hypothermia could alleviate ferroptosis induced by excessive inflammation and oxidative stress via the regulation of Keap1/GSK3β/Nrf2/GPX4 expression, hence ameliorating acute lung injury in sepsis.
- 1 October 2024
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 17, 7687-7704
Open AccessModerate Hypothermia Alleviates Sepsis-Associated Acute Lung Injury by Suppressing Ferroptosis Induced by Excessive Inflammation and Oxidative Stress via the Keap1/GSK3β/Nrf2/GPX4 Signaling Pathway
Purpose: Sepsis-associated acute lung injury (SA-ALI) is a common complication in patients with sepsis, contributing to high morbidity and mortality. Excessive inflammation and oxidative stress are crucial contributors to lung injury in sepsis. This study aims to examine the protective effects of moderate hypothermia on SA-ALI and explore the underlying mechanisms. Methods: Sepsis was induced in rats through cecal ligation and puncture followed by intervention with moderate hypothermia (32– 33.9°C). Blood, bronchoalveolar lavage fluid, and lung tissues were collected 12 hours post-surgery. Inflammatory responses, oxidative injury, SA-ALI-related pathophysiological processes, and Keap1/GSK3β/Nrf2/GPX4 signaling in septic rats were observed by ELISA, lung W/D ratio, immunohistochemistry, immunofluorescence, histological staining, Western blotting, RT-qPCR, and TEM assays. Results: Moderate hypothermia treatment alleviated lung injury in septic rats, reflected in amelioration of pathological changes in lung structure and improved pulmonary function. Further, moderate hypothermia reduced arterial blood lactate production and suppressed the expression of inflammatory factors IL-1β, IL-6, and TNF-α; downregulated ROS, MDA, and redox-active iron levels; and restored GSH and SOD content. TEM results demonstrated that moderate hypothermia could mitigate ferroptosis in PMVECs within lung tissue. The underlying mechanism may involve regulation of the Keap1/Nrf2/SLC7A11/GPX4 signaling pathway, with the insulin pathway PI3K/Akt/GSK3β also playing a partial role. Conclusion: Collectively, we illustrated a novel potential therapeutic mechanism in which moderate hypothermia could alleviate ferroptosis induced by excessive inflammation and oxidative stress via the regulation of Keap1/GSK3β/Nrf2/GPX4 expression, hence ameliorating acute lung injury in sepsis.
- Open Access
- 30 September 2024
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 186 (3) , 1-16
Identification of Immune-Related Genes as Potential Biomarkers in Early Septic Shock
Introduction: Septic shock, a severe manifestation of infection-induced systemic immune response, poses a critical threat resulting in life-threatening multi-organ failure. Early diagnosis and intervention are imperative due to the potential for irreversible organ damage. However, specific and sensitive detection tools for the diagnosis of septic shock are still lacking. Methods: Gene expression files of early septic shock were obtained from the Gene Expression Omnibus (GEO) database. CIBERSORT analysis was used to evaluate immune cell infiltration. Genes related to immunity and disease progression were identified using weighted gene co-expression network analysis (WGCNA), followed by enrichment analysis. CytoHubba was then employed to identify hub genes, and their relationships with immune cells were explored through correlation analysis. Blood samples from healthy controls and patients with early septic shock were collected to validate the expression of hub genes, and an external dataset was used to validate their diagnostic efficacy. Results: Twelve immune cells showed significant infiltration differences in early septic shock compared to control, such as neutrophils, M0 macrophages, and natural killer cells. The identified immune and disease-related genes were mainly enriched in immune, cell signaling, and metabolism pathways. In addition, six hub genes were identified (PECAM1, F11R, ITGAL, ICAM3, HK3, and MCEMP1), all significantly associated with M0 macrophages and exhibiting an area under curve of over 0.7. These genes exhibited abnormal expression in patients with early septic shock. External datasets and real-time qPCR validation supported the robustness of these findings. Conclusion: Six immune-related hub genes may be potential biomarkers for early septic shock.
- 30 September 2024
- Published by S. Karger AG in International Archives of Allergy and Immunology
- Vol. 186 (3) , 1-16
Open AccessIdentification of Immune-Related Genes as Potential Biomarkers in Early Septic Shock
Introduction: Septic shock, a severe manifestation of infection-induced systemic immune response, poses a critical threat resulting in life-threatening multi-organ failure. Early diagnosis and intervention are imperative due to the potential for irreversible organ damage. However, specific and sensitive detection tools for the diagnosis of septic shock are still lacking. Methods: Gene expression files of early septic shock were obtained from the Gene Expression Omnibus (GEO) database. CIBERSORT analysis was used to evaluate immune cell infiltration. Genes related to immunity and disease progression were identified using weighted gene co-expression network analysis (WGCNA), followed by enrichment analysis. CytoHubba was then employed to identify hub genes, and their relationships with immune cells were explored through correlation analysis. Blood samples from healthy controls and patients with early septic shock were collected to validate the expression of hub genes, and an external dataset was used to validate their diagnostic efficacy. Results: Twelve immune cells showed significant infiltration differences in early septic shock compared to control, such as neutrophils, M0 macrophages, and natural killer cells. The identified immune and disease-related genes were mainly enriched in immune, cell signaling, and metabolism pathways. In addition, six hub genes were identified (PECAM1, F11R, ITGAL, ICAM3, HK3, and MCEMP1), all significantly associated with M0 macrophages and exhibiting an area under curve of over 0.7. These genes exhibited abnormal expression in patients with early septic shock. External datasets and real-time qPCR validation supported the robustness of these findings. Conclusion: Six immune-related hub genes may be potential biomarkers for early septic shock.
- Open Access
- 31 July 2022
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2022, 1-11
Dexmedetomidine Attenuates LPS-Stimulated Alveolar Type II Cells’ Injury through Upregulation of miR-140-3p and Partial Suppression of PD-L1 Involving Inactivating JNK-Bnip3 Pathway
Dexmedetomidine (DEX), which is reported to be a newly discovered, novel α-2 adrenoceptor agonist, is known to exhibit anti-inflammatory properties in several diseases. DEX regulates inflammation-related signaling pathways and genes through interactions with several miRNAs. This study verified that expression levels of miR-140-3p were diminished when alveolar type II cells were exposed to LPS. However, the levels of miR-140-3p were confirmed as showing an increase with DEX treatment. These observations revealed that the expression of miR-140-3p was related to the beneficial effects that accompanied the DEX treatment of LPS-induced ALI. In addition, PD-1/PD-L1 expression increased extensively when RLE-6TN cells were induced by LPS. The increased expression was reduced after treatment with DEX. Thus, it appears that the PD-L1 expression was targeted directly by miR-140-3p, resulting in the partial repression of PD-L1 levels, which involved the inhibition of p-JNK and Bnip3 expression. Therefore, DEX was shown to inhibit the PD-L1 expression by promoting partially increased miR-140-3p levels in RLE-6TN cells. DEX also inactivated the JNK-Bnip3 pathway, resulting in the inhibition of inflammation and alleviating alveolar type II cell injury.
- 31 July 2022
- Published by Wiley in Canadian Respiratory Journal
- Vol. 2022, 1-11
Open AccessDexmedetomidine Attenuates LPS-Stimulated Alveolar Type II Cells’ Injury through Upregulation of miR-140-3p and Partial Suppression of PD-L1 Involving Inactivating JNK-Bnip3 Pathway
Dexmedetomidine (DEX), which is reported to be a newly discovered, novel α-2 adrenoceptor agonist, is known to exhibit anti-inflammatory properties in several diseases. DEX regulates inflammation-related signaling pathways and genes through interactions with several miRNAs. This study verified that expression levels of miR-140-3p were diminished when alveolar type II cells were exposed to LPS. However, the levels of miR-140-3p were confirmed as showing an increase with DEX treatment. These observations revealed that the expression of miR-140-3p was related to the beneficial effects that accompanied the DEX treatment of LPS-induced ALI. In addition, PD-1/PD-L1 expression increased extensively when RLE-6TN cells were induced by LPS. The increased expression was reduced after treatment with DEX. Thus, it appears that the PD-L1 expression was targeted directly by miR-140-3p, resulting in the partial repression of PD-L1 levels, which involved the inhibition of p-JNK and Bnip3 expression. Therefore, DEX was shown to inhibit the PD-L1 expression by promoting partially increased miR-140-3p levels in RLE-6TN cells. DEX also inactivated the JNK-Bnip3 pathway, resulting in the inhibition of inflammation and alleviating alveolar type II cell injury.
- Open Access
- 1 August 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 140, 111743
Cerebral and myocardial mitochondrial injury differ in a rat model of cardiac arrest and cardiopulmonary resuscitation
- 1 August 2021
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 140, 111743
Open AccessCerebral and myocardial mitochondrial injury differ in a rat model of cardiac arrest and cardiopulmonary resuscitation
- 1 December 2020
- Vol. 32 (12) , 1461-1466
[The effect of mild hypothermia on interleukin-3 expression in septic mice].
To investigate whether or not mild hypothermia can inhibit the expression and release of interleukin-3 (IL-3) in septic mice and whether it has a protective effect on septic mice. According to random number table method, 120 male C57BL/6 mice were divided into sham operation group (Sham group), sepsis normal temperature group (NT group) and sepsis mild hypothermia group (HT group), with 40 mice in each group. The acute septic mice model was established by cecal ligation and puncture (CLP) method. In the HT group, body temperature decreased to 32-34 centigrade at 1 hour after CLP and was maintained for 8 hours, followed by rewarming slowly to 36-38 centigrade. In the NT group, mice were resuscitated after CLP and body temperature was maintained at 36-38 centigrade throughout the experimental periods, while in Sham group, the cecum was not ligated or punctured and resuscitated routinely. The average arterial pressure (MAP) of 20 mice in each group was monitored for 12 hours after CLP, and the survival time was observed for 4 days. The serum of remaining mice was collected at 12 hours after CLP, and the mice were killed for organ tissues. The serum levels of IL-3, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were determined by enzyme linked immunosorbent assay (ELISA). Western blotting was used to detect IL-3 protein expression in spleen and lung tissues. The pathological changes of lung and liver tissues were observed under microscope and the semi-quantitative scoring was performed. MAP of NT group and HT group decreased after CLP with the prolongation of time. MAP (mmHg, 1 mmHg = 0.133 kPa) of HT group at 10 hours and 12 hours after CLP were significantly higher than those of NT group (10 hours: 74.4±12.4 vs. 62.9±7.2, 12 hours: 68.4±3.7 vs. 57.5±9.6, both P < 0.01). Compared with Sham group, serum levels of IL-3, IL-6 and TNF-α in NT group and HT group were significantly increased at 12 hours after CLP [IL-3 (ng/L): 2.21±0.87, 0.18±0.04 vs. 0, IL-6 (ng/L): 51.22±18.65, 24.68±6.20 vs. 1.36±0.34, TNF-α (ng/L): 101.43±38.60, 72.15±25.12 vs. 14.49±5.17, all P < 0.01]. IL-3 protein expressions of spleen and lung tissues in NT group and HT group were significantly increased compared to those in Sham group (IL-3/β-actin: spleen tissue 0.200±0.039, 0.135±0.023 vs. 0.090±0.023, lung tissue 0.085±0.009, 0.056±0.009 vs. 0.039±0.005, all P < 0.01). The serum levels of IL-3, IL-6 and TNF-α were significantly lower in HT group than those in the NT group [IL-3 (ng/L): 0.18±0.04 vs. 2.21±0.87, IL-6 (ng/L): 24.68±6.20 vs. 51.22±18.65, TNF-α (ng/L): 72.15±25.12 vs. 101.43±38.60, all P < 0.01]. The expressions of IL-3 protein in HT group were significantly lower than those in NT group (IL-3/β-actin: spleen tissue 0.135±0.023 vs. 0.200±0.039, lung tissue 0.056±0.009 vs. 0.085±0.009, both P < 0.01). The lung tissue injury and liver tissue injury scores in HT group were significantly lower than those in NT group (lung tissue injury score: 4.00±1.41 vs. 6.67±2.16, P = 0.03, liver tissue injury score: 3.83±1.47 vs. 7.17±2.14, P = 0.01). Compared to NT group, the 4-day survival rate of HT group was significantly improved (50% vs. 30%, P < 0.01). Mild hypothermia can significantly inhibit the expression and release of IL-3 in septic mice, attenuate organ injury, and protecte septic mice.
- 1 December 2020
- Vol. 32 (12) , 1461-1466
[The effect of mild hypothermia on interleukin-3 expression in septic mice].
To investigate whether or not mild hypothermia can inhibit the expression and release of interleukin-3 (IL-3) in septic mice and whether it has a protective effect on septic mice. According to random number table method, 120 male C57BL/6 mice were divided into sham operation group (Sham group), sepsis normal temperature group (NT group) and sepsis mild hypothermia group (HT group), with 40 mice in each group. The acute septic mice model was established by cecal ligation and puncture (CLP) method. In the HT group, body temperature decreased to 32-34 centigrade at 1 hour after CLP and was maintained for 8 hours, followed by rewarming slowly to 36-38 centigrade. In the NT group, mice were resuscitated after CLP and body temperature was maintained at 36-38 centigrade throughout the experimental periods, while in Sham group, the cecum was not ligated or punctured and resuscitated routinely. The average arterial pressure (MAP) of 20 mice in each group was monitored for 12 hours after CLP, and the survival time was observed for 4 days. The serum of remaining mice was collected at 12 hours after CLP, and the mice were killed for organ tissues. The serum levels of IL-3, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were determined by enzyme linked immunosorbent assay (ELISA). Western blotting was used to detect IL-3 protein expression in spleen and lung tissues. The pathological changes of lung and liver tissues were observed under microscope and the semi-quantitative scoring was performed. MAP of NT group and HT group decreased after CLP with the prolongation of time. MAP (mmHg, 1 mmHg = 0.133 kPa) of HT group at 10 hours and 12 hours after CLP were significantly higher than those of NT group (10 hours: 74.4±12.4 vs. 62.9±7.2, 12 hours: 68.4±3.7 vs. 57.5±9.6, both P < 0.01). Compared with Sham group, serum levels of IL-3, IL-6 and TNF-α in NT group and HT group were significantly increased at 12 hours after CLP [IL-3 (ng/L): 2.21±0.87, 0.18±0.04 vs. 0, IL-6 (ng/L): 51.22±18.65, 24.68±6.20 vs. 1.36±0.34, TNF-α (ng/L): 101.43±38.60, 72.15±25.12 vs. 14.49±5.17, all P < 0.01]. IL-3 protein expressions of spleen and lung tissues in NT group and HT group were significantly increased compared to those in Sham group (IL-3/β-actin: spleen tissue 0.200±0.039, 0.135±0.023 vs. 0.090±0.023, lung tissue 0.085±0.009, 0.056±0.009 vs. 0.039±0.005, all P < 0.01). The serum levels of IL-3, IL-6 and TNF-α were significantly lower in HT group than those in the NT group [IL-3 (ng/L): 0.18±0.04 vs. 2.21±0.87, IL-6 (ng/L): 24.68±6.20 vs. 51.22±18.65, TNF-α (ng/L): 72.15±25.12 vs. 101.43±38.60, all P < 0.01]. The expressions of IL-3 protein in HT group were significantly lower than those in NT group (IL-3/β-actin: spleen tissue 0.135±0.023 vs. 0.200±0.039, lung tissue 0.056±0.009 vs. 0.085±0.009, both P < 0.01). The lung tissue injury and liver tissue injury scores in HT group were significantly lower than those in NT group (lung tissue injury score: 4.00±1.41 vs. 6.67±2.16, P = 0.03, liver tissue injury score: 3.83±1.47 vs. 7.17±2.14, P = 0.01). Compared to NT group, the 4-day survival rate of HT group was significantly improved (50% vs. 30%, P < 0.01). Mild hypothermia can significantly inhibit the expression and release of IL-3 in septic mice, attenuate organ injury, and protecte septic mice.
- Open Access
- 18 February 2019
- Published by Springer Nature in Journal of Inflammation
- Vol. 16 (1) , 1-10
LDK378 improves micro- and macro-circulation via alleviating STING-mediated inflammatory injury in a Sepsis rat model induced by Cecal ligation and puncture
Sepsis is a systemic inflammatory response syndrome caused by severe infections. LDK378, a second-generation ALK inhibitor, exhibits a potential anti-inflammatory function against sepsis. Micro- and macro-circulatory dysfunctions are pivotal elements of the pathogenesis of severe sepsis and septic shock. We hypothesized that LDK378 can improve micro- and macro-circulation of septic rats, therefore improving the outcome of survival via blocking the ALK-STING pathway to attenuate inflammatory injuries. A septic rat model was established by the cecal ligation and puncture (CLP) method. A total of 60 rats were randomized into three groups: a sham group, CLP group, and CLP + LDK378 group (n = 20 in each group). Five rats were randomly selected from each group for the mechanism study; the remaining 15 rats in each group were involved in a survival curve examination. A sidestream dark field video microscope was used to record sublingual microcirculation and mean arterial pressure (MAP) and levels of inflammatory cytokine secretion were examined at 6 h, 30 h, and 54 h after CLP surgery. Expressions of TANK binding kinase 1 (TBK1) and its downstream targets were determined, and histological alterations to the heart, lungs, and kidneys were examined at 54 h after CLP surgery. We found the group that received LDK378 treatment showed increased MAP levels compared to the CLP group at 30 h and 54 h. Meanwhile, LDK378 ameliorated the perfused small vessel density and microvascular flow index, decreased the expression of TNF-a and IL-6, and upregulated the expression of IL-10 in comparison with the CLP group. LDK378 injections also downregulated the expression of TBK1 and its downstream targets. Furthermore, LDK378 treatment significantly reduced sepsis-induced organ injuries, therefore improving survival rates. These findings demonstrate that LDK378 treatment can improve microcirculation and reduce organ injuries in CLP-induced septic rats via the regulation of inflammatory cytokine secretion and the downstream signaling components of the ALK-STING pathway.
- 18 February 2019
- Published by Springer Nature in Journal of Inflammation
- Vol. 16 (1) , 1-10
Open AccessLDK378 improves micro- and macro-circulation via alleviating STING-mediated inflammatory injury in a Sepsis rat model induced by Cecal ligation and puncture
Sepsis is a systemic inflammatory response syndrome caused by severe infections. LDK378, a second-generation ALK inhibitor, exhibits a potential anti-inflammatory function against sepsis. Micro- and macro-circulatory dysfunctions are pivotal elements of the pathogenesis of severe sepsis and septic shock. We hypothesized that LDK378 can improve micro- and macro-circulation of septic rats, therefore improving the outcome of survival via blocking the ALK-STING pathway to attenuate inflammatory injuries. A septic rat model was established by the cecal ligation and puncture (CLP) method. A total of 60 rats were randomized into three groups: a sham group, CLP group, and CLP + LDK378 group (n = 20 in each group). Five rats were randomly selected from each group for the mechanism study; the remaining 15 rats in each group were involved in a survival curve examination. A sidestream dark field video microscope was used to record sublingual microcirculation and mean arterial pressure (MAP) and levels of inflammatory cytokine secretion were examined at 6 h, 30 h, and 54 h after CLP surgery. Expressions of TANK binding kinase 1 (TBK1) and its downstream targets were determined, and histological alterations to the heart, lungs, and kidneys were examined at 54 h after CLP surgery. We found the group that received LDK378 treatment showed increased MAP levels compared to the CLP group at 30 h and 54 h. Meanwhile, LDK378 ameliorated the perfused small vessel density and microvascular flow index, decreased the expression of TNF-a and IL-6, and upregulated the expression of IL-10 in comparison with the CLP group. LDK378 injections also downregulated the expression of TBK1 and its downstream targets. Furthermore, LDK378 treatment significantly reduced sepsis-induced organ injuries, therefore improving survival rates. These findings demonstrate that LDK378 treatment can improve microcirculation and reduce organ injuries in CLP-induced septic rats via the regulation of inflammatory cytokine secretion and the downstream signaling components of the ALK-STING pathway.